產(chǎn)品詳情
簡單介紹：
Anti-Cyclin D1抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-Cyclin D1抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-Cyclin D1
Cat. Number:
Anti-Cyclin D1抗體KL-0623R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The protein encoded byAnti-Cyclin D1抗體 this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. [provided by RefSeq, Jul 2008].
Also known as:
Cyclin D1; CyclinD1; Cyclin-D1; Anti-Cyclin D1抗體B cell ccl/lymphoma 1; B cell leukemia 1; B-cell CLL/lymphoma 1; B-cell leukemia 1; B-cell lymphoma 1 protein; BCL-1; BCL1; BCL1 oncogene; CCND 1; CCND1; CCND1 protein; CCND1/FSTL3 fusion gene, included; CCND1/IGHG1 fusion gene; CCND1/IGHG1 fusion gene, included; CCND1/IGLC1 fusion gene, included; CCND1/PTH fusion gene, included; Parathyroid adenomatosis 1; PRAD1; FSTL3; CCND1_HUMAN; AI327039; B cell lymphoma 1 protein; BCL 1; BCL-1; BCL-1 oncogene; BCL1 oncogene; CCND1/FSTL3 fusion gene, included; cD1; Cyl 1; D11S287E; G1/S specific cyclin D1; G1/S-specific cyclin-D1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Anti-Cyclin D1抗體Mouse, Rat, Dog, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Cyclin D1 N-terminus.
●
Predicted Molecular Weight: 32kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 Anti-Cyclin D1抗體ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:20-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl613Hu01 谷胱甘肽S轉(zhuǎn)移酶θ2(GSTθ2)多克隆抗體 Polyclonal Antibody to Glutathione S Transferase Theta 2 (GSTt2)
kl613Mu01 谷胱甘肽S轉(zhuǎn)移酶θ2(GSTθ2)多克隆抗體 Polyclonal Antibody to Glutathione S Transferase Theta 2 (GSTt2)
kl613Ra01 谷胱甘肽S轉(zhuǎn)移酶θ2(GSTθ2)多克隆抗體 Polyclonal Antibody to Glutathione S Transferase Theta 2 (GSTt2)
kl615Hu01 纖溶抑制因子(TAFI)多克隆抗體 Polyclonal Antibody to Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
kl615Mu01 纖溶抑制因子(TAFI)多克隆抗體 Polyclonal Antibody to Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
kl615Ra01 纖溶抑制因子(TAFI)多克隆抗體 Polyclonal Antibody to Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
kl616Hu01 V-Rel網(wǎng)狀內(nèi)皮增生病毒癌基因同源物A(RELA)多克隆抗體 Polyclonal Antibody to V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)
kl616Mu01 V-Rel網(wǎng)狀內(nèi)皮增生病毒癌基因同源物A(RELA)多克隆抗體 Polyclonal Antibody to V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)
kl616Ra01 V-Rel網(wǎng)狀內(nèi)皮增生病毒癌基因同源物A(RELA)多克隆抗體 Polyclonal Antibody to V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)
kl618Hu01 速激肽受體2(TACR2)多克隆抗體 Polyclonal Antibody to Tachykinin Receptor 2 (TACR2)
kl618Mu01 速激肽受體2(TACR2)多克隆抗體 Polyclonal Antibody to Tachykinin Receptor 2 (TACR2)
